UNITÉ DE FABRICATION DES MÉDICAMENTS S.A

Unité de Fabrication des Médicaments S.A

UMED

TN0007720014

Pharmaceuticals

End-of-day quote Tunis Other stock markets 18:00:00 2024-05-13 EDT			5-day change	1st Jan Change
7.09 ^TND	-0.14%		-2.88%	-5.21%

2023	Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Unite De Fabrication De Medicaments SA has filed an IPO.

March 22, 2016 at 12:00 am

Latest news about Unité de Fabrication des Médicaments S.A

Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-02	CI
Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-04	CI
Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-13	CI
Unité de Fabrication des Médicaments S.A Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-14	CI
Unité de Fabrication des Médicaments Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-20	CI
Unité De Fabrication Des Médicaments Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-20	CI
Ridha Charfeddine and others acquired 6.85% stake in Unité de Fabrication des Médicaments from SQM Frontier Africa Master Fund, Ltd., managed by SQM Frontier Management, LP.	20-08-22	CI
Unite De Fabrication De Medicaments SA(BVMT:UMED) added to S&P Pan Arab Composite	16-06-20	CI
Unite De Fabrication De Medicaments SA has completed an IPO in the amount of TND 43.22 million.	16-05-03	CI
Unite De Fabrication De Medicaments SA has filed an IPO.	16-03-22	CI
SQM Frontier Management, LP, Consortium Tuniso-Koweitien de Developpement, Blakeney Asset Management of Miles Morland Foundation, and two local investors acquired 83% stake in Unite De Fabrication De Medicaments SA from PROPARCO SA and The Abraaj Group.	15-12-22	CI

Chart Unité de Fabrication des Médicaments S.A

Duration

Period

Chart Unité de Fabrication des Médicaments S.A

More charts

Unimed (Unité de Fabrication de Médicaments) is one of the leading pharmaceutical groups in Tunisia. The activity is organized around 2 families of products: - generic medicines: primarily infusion and inhalation products, ophthalmic products, injectable liquids and powders; - fashioned medicines: medicines manufactured for third parties.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Unité de Fabrication des Médicaments S.A

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.09 TND

Average target price

11.9 TND

Spread / Average Target

+67.84%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
UNITÉ DE FABRICATION DES MÉDICAMENTS S.A	-5.21%	72.64M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.60%	364B
MERCK & CO., INC.	+20.83%	326B
ABBVIE INC.	+5.69%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+10.77%	167B
PFIZER, INC.	+0.10%	161B

Other Pharmaceuticals

Unité de Fabrication des Médicaments S.A

Equities

UMED

TN0007720014

Pharmaceuticals

Unite De Fabrication De Medicaments SA has filed an IPO.

Latest news about Unité de Fabrication des Médicaments S.A

Chart Unité de Fabrication des Médicaments S.A

Company Profile

Income Statement Evolution

Ratings for Unité de Fabrication des Médicaments S.A

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals